Friday, April 15, 2016

UPDATE 2-EU extends safety review of chronic hep C treatments

* Names hep C drugs from J&J, Gilead, AbbVie

(Adds details)

Read more

Latest battle to wipe out polio begins with vast vaccine switch

LONDON, April 15 (Reuters) - In a huge immunisation effort

in 150 countries, health teams will on Sunday launch what they

hope will be the final push against polio.

Read more

BRIEF-Ocera Therapeutics says two preclinical studies further support its ammonia scavenger OCR-002

April 15 (Reuters) - Ocera Therapeutics Announces

Presentation Of Two Preclinical Studies Further Supporting Its

Ammonia Scavenger Ocr

Read more

BRIEF-Marinus Pharmaceuticals' ganaxolone IV receives FDA orphan drug designation

* Marinus Pharmaceuticals receives FDA orphan drug

designation for ganaxolone IV to treat status epilepticus

Read more

WIDER IMAGE-Students run mobile amputee clinic in Syria

Maaret al-Numan, SYRIA, April 14 (Reuters) - In what looks

like an ordinary white truck, two men are helping victims who

have lost limbs in the conflict in Syria to walk, play, and even

herd sheep again.

Read more

Deals of the day- Mergers and acquisitions

April 15 (Reuters) - The following bids, mergers,

acquisitions and disposals were reported by 1200 GMT on Friday:

Read more

CANADA STOCKS-Futures weak as oil prices fall before producers' meet

April 15 (Reuters) - Stock futures pointed to a lower start

for Canada's main stock index on Friday as crude futures fell

more than 2 percent ahead of an oil producers' meeting in Doha

to rein in a global glut.

Read more